NovoCure Limited - Ordinary Shares · Transaction Jul 2, 2021 · Filed Aug 5, 2021 · $15,001 to $50,000
NASDAQ NMS - GLOBAL MARKET · NVCR
-2.24% · -$0.3600 · Vol 943.3K
After hours · updated 16:01:00 ET
Novocure Ltd
Health Care
$15.69
Veridion Score
BETAHIGH CONF · 6/6 factorsStale score · Wed Aug 5 · completed session · 27h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET · NVCR
MethodologyNVCR
Novocure Ltd
Stale score · Wed Aug 5 · completed session · 27h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
65/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Stale score · Wed Aug 5 · completed session · 27h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is NVCR moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Novocure Ltd
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
2015
Employees
2K
Country
JE
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$16.20
Day high
$16.20
Day low
$15.58
Previous close
$16.05
52W high
$19.99
-21.51% from high
52W low
$10.03
57% of range
Market cap
$1.9B
EPS
$-1.1300
Beta
1.08
Shares out
116.4M
Volume
943.3K
0.53× rel vol
Avg volume
1.8M
VWAP
$15.79
Price history computed in-house
1W
+3.02%
1M
-11.46%
3M
-12.30%
1Y
+37.75%
YTD
+21.35%
SMA 50 $16.36 · below
SMA 200 $13.83 · above
52W position 57%
NVCR overview
Veridion Score
65
6 of 6 factors measured
Congress receipts
3
Marie Newman · Purchase
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in NVCR
Official filing ↗
Donna ShalalaSell
NVCR · Transaction Jun 24, 2019 · Filed Apr 27, 2020 · $1,001 to $15,000
NVCR · Transaction Jun 19, 2019 · Filed Apr 27, 2020 · $1,001 to $15,000
Federal contracts
NVCR contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NVCR in this window.
Lobbying spend
NVCR lobbying filings, year to date.
Registered lobbying filings matched to Novocure Ltd.
$610.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid
Health IssuesMedicare/Medicaid
Tariff (miscellaneous tariff bills)Tariff (miscellaneous tariff bills)
Medicare/Medicaid
Filing
$180.0K
NOVOCURE INC.
NOVOCURE INC.
Apr 20, 2026
Filing
$160.0K
NOVOCURE INC.
NOVOCURE INC.
Jul 19, 2026
Filing
$110.0K
NOVOCURE INC.
NOVOCURE INC.
Jan 17, 2026
Analyst ratings
Sovereign unlock shows live analyst consensus for NVCR.
Options
Sovereign unlock shows live options positioning for NVCR.